Validating Multi-gene Prognostic Assays in Breast Cancer on the NanoString N-Counter PlatformThursday, 12 September 2013 at 17:15  Add to Calendar ▼2013-09-12 17:15:002013-09-12 18:15:00Europe/LondonValidating Multi-gene Prognostic Assays in Breast Cancer on the NanoString N-Counter PlatformMicroarray World Congress in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.comFor diagnostic applications, multiplex RNA assays must demonstrate robust performance in technically challenging specimens such as formalin-fixed paraffin-embedded (FFPE) tissues. This talk will address the reliability and reproducibility of the NanoString nCounter platform toward development of clinically-actionable gene expression signatures in breast cancer. |
Add to Calendar ▼2013-09-12 00:00:002013-09-13 00:00:00Europe/LondonMicroarray World CongressMicroarray World Congress in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com
